WO2002018350A1 - Grk inhibitor - Google Patents
Grk inhibitor Download PDFInfo
- Publication number
- WO2002018350A1 WO2002018350A1 PCT/JP2001/007397 JP0107397W WO0218350A1 WO 2002018350 A1 WO2002018350 A1 WO 2002018350A1 JP 0107397 W JP0107397 W JP 0107397W WO 0218350 A1 WO0218350 A1 WO 0218350A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- ring
- grk inhibitor
- represents optionally
- grk
- inhibitor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2001282520A AU2001282520A1 (en) | 2000-08-29 | 2001-08-29 | Grk inhibitor |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000264499 | 2000-08-29 | ||
JP2000-264499 | 2000-08-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2002018350A1 true WO2002018350A1 (en) | 2002-03-07 |
Family
ID=18751904
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2001/007397 WO2002018350A1 (en) | 2000-08-29 | 2001-08-29 | Grk inhibitor |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2001282520A1 (en) |
WO (1) | WO2002018350A1 (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005037271A2 (en) * | 2003-10-17 | 2005-04-28 | Tanabe Seiyaku Co., Ltd. | Large conductance calcium-activated k channel opener |
WO2008001883A1 (en) | 2006-06-29 | 2008-01-03 | Nissan Chemical Industries, Ltd. | α-AMINO ACID DERIVATIVE AND PHARMACEUTICAL COMPRISING THE SAME AS ACTIVE INGREDIENT |
US7482350B2 (en) | 2004-05-08 | 2009-01-27 | Neurogen Corporation | 4,5-disubstituted-2-aryl pyrimidines |
US8748442B2 (en) | 2010-06-30 | 2014-06-10 | Ironwood Pharmaceuticals, Inc. | sGC stimulators |
US9061030B2 (en) | 2010-11-09 | 2015-06-23 | Ironwood Pharmaceuticals, Inc. | sGC stimulators |
US9139564B2 (en) | 2011-12-27 | 2015-09-22 | Ironwood Pharmaceuticals, Inc. | 2-benzyl, 3-(pyrimidin-2-yl) substituted pyrazoles useful as sGC stimulators |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS63126868A (en) * | 1986-10-18 | 1988-05-30 | ザ ウエルカム フアウンデーシヨン リミテツド | Compound or salt thereof, pharmaceutical preparation containing the same, remedy or prevention of tumor breeding of animal, production of said compound and novel chemical intermediate |
JPH029869A (en) * | 1988-04-15 | 1990-01-12 | Wellcome Found Ltd:The | Novel compound |
-
2001
- 2001-08-29 WO PCT/JP2001/007397 patent/WO2002018350A1/en active Application Filing
- 2001-08-29 AU AU2001282520A patent/AU2001282520A1/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS63126868A (en) * | 1986-10-18 | 1988-05-30 | ザ ウエルカム フアウンデーシヨン リミテツド | Compound or salt thereof, pharmaceutical preparation containing the same, remedy or prevention of tumor breeding of animal, production of said compound and novel chemical intermediate |
JPH029869A (en) * | 1988-04-15 | 1990-01-12 | Wellcome Found Ltd:The | Novel compound |
Non-Patent Citations (8)
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005037271A2 (en) * | 2003-10-17 | 2005-04-28 | Tanabe Seiyaku Co., Ltd. | Large conductance calcium-activated k channel opener |
WO2005037271A3 (en) * | 2003-10-17 | 2005-09-01 | Tanabe Seiyaku Co | Large conductance calcium-activated k channel opener |
US7482350B2 (en) | 2004-05-08 | 2009-01-27 | Neurogen Corporation | 4,5-disubstituted-2-aryl pyrimidines |
US8129395B2 (en) | 2004-05-08 | 2012-03-06 | Novartis International Pharmaceutical Ltd. | 4,5-disubstituted-2-aryl pyrimidines |
WO2008001883A1 (en) | 2006-06-29 | 2008-01-03 | Nissan Chemical Industries, Ltd. | α-AMINO ACID DERIVATIVE AND PHARMACEUTICAL COMPRISING THE SAME AS ACTIVE INGREDIENT |
US7879887B2 (en) | 2006-06-29 | 2011-02-01 | Nissan Chemical Industries, Ltd. | α-amino acid derivatives and medicaments containing the same as an active ingredient |
US8748442B2 (en) | 2010-06-30 | 2014-06-10 | Ironwood Pharmaceuticals, Inc. | sGC stimulators |
US10189809B2 (en) | 2010-06-30 | 2019-01-29 | Ironwood Pharmaceuticals, Inc. | SGC stimulators |
US9061030B2 (en) | 2010-11-09 | 2015-06-23 | Ironwood Pharmaceuticals, Inc. | sGC stimulators |
US9139564B2 (en) | 2011-12-27 | 2015-09-22 | Ironwood Pharmaceuticals, Inc. | 2-benzyl, 3-(pyrimidin-2-yl) substituted pyrazoles useful as sGC stimulators |
Also Published As
Publication number | Publication date |
---|---|
AU2001282520A1 (en) | 2002-03-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2322171A1 (en) | Cyclic amino compounds | |
WO2001017972A3 (en) | Novel herbicides | |
WO2002062792A1 (en) | Jnk inhibitor | |
WO2001070671A3 (en) | Insecticidal anthranilamides | |
EP1471065A4 (en) | Novel 1,2,4-triazole compound | |
WO2001019828A3 (en) | Kinase inhibitors as therapeutic agents | |
EP1182195A4 (en) | Cyclic compounds and uses thereof | |
DE69919397D1 (en) | Thrombin Inhibitors | |
MXPA04002647A (en) | Arthropodicidal anthranilamides. | |
TW200738629A (en) | Ethylenediamine derivatives | |
WO1992015607A3 (en) | Phenyl amidines derivatives useful as platelet aggregation inhibitors | |
EP1568699A4 (en) | 1,3-dihydroimidazole fused-ring compound | |
EP1704856A4 (en) | Hsp90 family protein inhibitor | |
WO1998005652A3 (en) | Arthropodicidal and fungicidal cyclic amides | |
EP1634874A4 (en) | Imidazolidine derivative | |
WO2001072263A3 (en) | Use of ectoin or ectoin derivatives for protecting stress proteins in the skin | |
WO2003049690A3 (en) | Hiv integrase inhibitors | |
ID24846A (en) | BIFENYLAMIDINE DECLINES | |
ES2083625T3 (en) | DERIVATIVES OF N-FENILTIOUREA AND PHARMACEUTICAL USE THEREOF. | |
WO2002018350A1 (en) | Grk inhibitor | |
WO2003035650A1 (en) | Entry inhibitor | |
MY129094A (en) | Condensed polycyclic compounds | |
EP1362850A4 (en) | Oxime ether compound and agricultural or horticultural bactericide | |
WO2004099130A3 (en) | 1,2-diarylimidazoles useful as inhibitors of cox | |
DK1340756T3 (en) | New beta-lactam compounds and processes for their preparation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |